Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of cellular and inflammatory imaging (USPIO SH U 555 C) vs 3T multimodal MRI in multiple sclerosis lesions and progression
2007-005362-12Phase 2Active
- Sponsor
- CHU Rennes
- Start
- Feb 2008
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, single-arm trial of SH U 555 C in multiple sclerosis (MS), sponsored by CHU Rennes. Primary endpoints: Comparison and quantification of USPIO vs gadolinium-enhancing MS lesions and Correlation of MRI lesion findings with clinical disability (EDSS). Started Feb 2008; status: active.
02
Drugs
SH U 555 C
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2007-005362-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005362-12.